UCB Australia Pty Ltd
ABN 48 005 799 208
Level 1, 1155 Malvern Road, Malvern VIC 3144
Our UCB Cares team are available to support patients, doctors, pharmacists and other healthcare professionals with enquiries about UCB medications.
To report suspected adverse reactions
Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions to the TGA at http://www.tga.gov.au/reporting-problems and UCB.
General Business Enquiries
AU-N-BK-PSO-2100017 May 2023